Cholera Vaccines Market
Report ID: SQMIG35I2103
Report ID: SQMIG35I2103
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35I2103 |
Region:
Global |
Published Date: December, 2025
Pages:
219
|Tables:
65
|Figures:
75
Global Cholera Vaccines Market size was valued at USD 86.7 Million in 2024 and is poised to grow from USD 93.72 Million in 2025 to USD 174.76 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026–2033).
Tainted food and water transmit the bacterial infections that cause cholera and affect the intestines. In addition to muscle cramps and dry mucous membranes like those on the inside of the mouth, throat, nose, and eyelids, it causes severe diarrhea, dehydration, abdominal pain, fever, a quick heartbeat, loss of skin elasticity, low blood pressure, and rapid heart rate. Currently, it threatens public health globally, but vaccination can stop it. The cholera vaccine exposes the body to a small number of live cholera bacteria, aiding in the development of immunity. It can be administered intravenously, intramuscularly, or orally. A biological preparation known as a vaccine helps the immune system develop and gives immunity to specific infectious illnesses. Many international institutions, like the World Health Organization, employ vaccines to treat infectious diseases (WHO). One contagious sickness known as cholera is brought on by consuming food or water tainted with the vibrio cholera bacterium. The infection is characterized by profuse watery diarrhea and has a brief incubation period of a few hours to five days. Sometimes cholera can be lethal. The disease is intimately associated with unhygienic behavior, inadequate sanitization, and a lack of safe drinking water. It occurs in both endemic and epidemic patterns.
US Cholera Vaccines Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2026-2033
Global Market Size
USD 80.2 million
Largest Segment
Dukoral
Fastest Growth
Dukoral
Growth Rate
8.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Cholera Vaccines Market is segmented by Type, Product, Route of Administration, End User, Age Group, Distribution Channel and region. Based on Type, the market is segmented into Whole Cell V. Cholerae O1 with Recombinant B- subunit and Killed Oral O1 and O139. Based on Product, the market is segmented into Vaxchora, Dukoral, Shanchol and Other Products. Based on Route of Administration, the market is segmented into Injectables Vaccines and Oral Vaccines. Based on End User, the market is segmented into Hospitals, Homecare, Specialty Clinics and Others. Based on Age Group, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Online Pharmacy and Retail Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on classification by type,, the market is divided into Dukoral, Shanchol, Vaxchora, Euvichol, and others, with the Dukoral segment holding the largest market share. The segment's growth can be attributed primarily to the availability of a significant volume of this product as stockpiled by the WHO, as well as the high demand for these vaccines among international travellers, the volume of which is rapidly increasing in low- and middle-income countries. This segment is further projected to continue dominating the market in the near future.
As per classification by end user, the market is segmented into hospitals, specialty clinics, research and academic laboratory and pharmaceutical and biotechnology companies and others. Research and academic laboratories segment is projected to exhibit the highest growth during the forecast period. This is attributed to the rise in demand for cholera vaccine across the world. Thus, helps in increasing the cholera vaccine market size in the near future.
To get detailed segments analysis, Request a Free Sample Report
The market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa (MEA). According to regional analysis, Asia-Pacific has the largest market share. This is due to increased access to effective preventive measures, rise in public awareness of the disease, and the disease's high incidence rate. Europe is also expected to grow steadily during the forecast period, owing to the region's well-established healthcare infrastructure. North America, on the other hand, is expected to grow at a faster rate during the forecast period, owing to rising consumption of contaminated food, a lack of appropriate hygiene, and an increasing number of migrants. At the same time, increased R&D activities, rising public awareness of vaccination, and rising government initiatives to conduct immunisation programmes would all contribute to the growth of the cholera vaccine market in this region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Unhealthy Lifestyles and Poor Sanitation Issues to Prevail in Cholera
Longer Production Time for Cholera Vaccines may Hamper Growth
Request Free Customization of this report to help us to meet your business objectives.
In May 2023, the International Vaccine Institute (IVI) began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in capsule form. With funding support from the Wellcome Trust and the Swedish government, IVI is preparing to conduct a Phase I clinical trial of the vaccine in Sweden.
In February 2023, Bavarian Nordic completed the acquisition of Emergent BioSolutions' travel vaccine portfolio for an upfront payment of $274million, with the potential for the total value to rise to $384million. The deal encompasses Vivotif and Vaxchora, both marketed vaccines for the prevention of typhoid fever and cholera respectively, and a Phase III vaccine candidate for the prevention of Chikungunya virus, which have now all been transferred to Bavarian Nordic.
In November 2022, South Africa's Biovac Institute signed a licensing and technology transfer deal with the International Vaccine Institute (IVI) to develop and make oral cholera vaccine for African and global markets.
SkyQuest's ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, The market for cholera vaccines is anticipated to increase significantly during the forecast period as a result of rising venous disease prevalence and rising new product approvals to meet this need. The market is expected to develop as a result of rising disease awareness, growing value of early detection, and rising spending on chronic illnesses. Additionally, the major market participants are spending money on the development of technologically improved goods, which will expand the use of cholera vaccines in both developed and developing nations.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 86.7 Million |
| Market size value in 2033 | USD 174.76 Million |
| Growth Rate | 8.1% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Cholera Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cholera Vaccines Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cholera Vaccines Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cholera Vaccines Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
